Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,084,861 papers from all fields of science
Search
Sign In
Create Free Account
CDKN2A wt Allele
Known as:
TP16
, p14ARF
, P16INK4
Expand
Human CDKN2A wild-type allele is located in the vicinity of 9p21 and is approximately 27 kb in length. This allele, which encodes both cyclin…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
24 relations
9p21
Beckwith-Wiedemann Syndrome
CDKN2B gene
CTCF Pathway
Expand
Broader (1)
CDKN2A gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
The Negative Predictive Value of p16INK4a to Assess the Outcome of Cervical Intraepithelial Neoplasia 1 in the Uterine Cervix
J. Hariri
,
A. Øster
International Journal of Gynecological Pathology
2007
Corpus ID: 24931292
Summary: The immunohistochemical expression of p16INK4a in formalin-fixed and paraffin-embedded histological sections was…
Expand
Review
2005
Review
2005
New and unexpected: forkhead meets ARF.
R. Costa
,
V. Kalinichenko
,
M. Major
,
P. Raychaudhuri
Current Opinion in Genetics and Development
2005
Corpus ID: 30376691
Highly Cited
2005
Highly Cited
2005
Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.
Yu-Chien Wang
,
Ruo-Kai Lin
,
Y. Tan
,
Jung‐Ta Chen
,
Chih‐Yi Chen
,
Yi-Ching Wang
Journal of Clinical Oncology
2005
Corpus ID: 29195756
PURPOSE We found a relatively reduced frequency of p53 mutation with a much greater frequency of p53 protein overexpression…
Expand
Highly Cited
1999
Highly Cited
1999
Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
M. Sanchez-Cespedes
,
A. Reed
,
+6 authors
D. Sidransky
Oncogene
1999
Corpus ID: 5874647
Inactivation of the P16 (INK4A)/retinoblastoma (RB) or TP53 biochemical pathway is frequent event in most human cancers. Recent…
Expand
Highly Cited
1997
Highly Cited
1997
Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV
A. Olshan
,
M. Weissler
,
+4 authors
W. Yarbrough
Oncogene
1997
Corpus ID: 12770547
Alterations, especially homozygous deletions, of the putative tumor suppressor gene, p16 (p16INK4A, MTS1, CDKN2) have been found…
Expand
Highly Cited
1996
Highly Cited
1996
Alterations of the p15, p16,and p18 genes in osteosarcoma.
C. Miller
,
A. Aslo
,
M. Campbell
,
N. Kawamata
,
B. Lampkin
,
H. Koeffler
Cancer Genetics and Cytogenetics
1996
Corpus ID: 27937194
Highly Cited
1995
Highly Cited
1995
CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple‐mole melanoma (FAMMM) syndrome families
N. Gruis
,
L. Sandkuijl
,
P. A. van der Velden
,
W. Bergman
,
R. Frants
Melanoma research
1995
Corpus ID: 11202068
Combined multi-point linkage analysis in seven Dutch families with FAMMM syndrome confirmed the location of a melanoma…
Expand
Highly Cited
1995
Highly Cited
1995
Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.
E. Holland
,
S. Beaton
,
+5 authors
G. Mann
Oncogene
1995
Corpus ID: 39973872
CDKN2 has been implicated as a melanoma susceptibility gene in some kindreds with a family history of this disease. Mutation…
Expand
Highly Cited
1995
Highly Cited
1995
Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.
J. Glendening
,
J. Flores
,
G. Walker
,
S. Stone
,
A. Albino
,
J. Fountain
Cancer Research
1995
Corpus ID: 358790
Homozygous deletions of 9p21, including the cyclin-dependent kinase inhibitor genes p16INK4 and p15INK4B, have been reported…
Expand
Highly Cited
1994
Highly Cited
1994
Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.
L. Xu
,
D. Sgroi
,
+7 authors
D. Louis
Cancer Research
1994
Corpus ID: 43817131
The CDKN2 gene that encodes the cell cycle regulatory protein cyclin-dependent kinase-4 inhibitor (p16) has recently been mapped…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required